The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray.
about
Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulationScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data.Orphan nuclear receptor NR4A1 is a negative regulator of DHT-induced rat preantral follicular growth.Downregulation of both gene expression and activity of Hsp27 improved maturation of mouse oocyte in vitroMetabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids.The intraovarian actions of estrogen receptor-alpha are necessary to repress the formation of morphological and functional Leydig-like cells in the female gonad.Ovarian reserve status in young women is associated with altered gene expression in membrana granulosa cells.Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling.Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patientsSET protein up-regulated testosterone production in the cultured preantral follicles.Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia.Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model.Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome.Granulosa cell survival and proliferation are altered in polycystic ovary syndrome.PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update.Genetic investigation into ethnic disparity in polycystic ovarian syndrome.Circulating microRNAs in patients with polycystic ovary syndrome.Differential genes in adipocytes induced from polycystic and non-polycystic ovary syndrome-derived human embryonic stem cells.Establishment of polycystic ovary syndrome-derived human embryonic stem cell lines.Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women.The NGFI-B family of transcription factors regulates expression of 3beta-hydroxysteroid dehydrogenase type 2 in the human ovary.Attenuated expression of MTR in both prenatally androgenized mice and women with the hyperandrogenic phenotype of PCOS.Development and identification of Set transgenic mice.The SET protein promotes androgen production in testicular Leydig cells.Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS
P2860
Q24616428-8F16CACE-407D-4A0F-9DF1-332F8500CBC7Q28390200-B68DA2C8-A22A-4D26-A790-137CE82E0675Q33399651-D23CC638-E6A2-4EFF-87AE-733C182282D1Q33499079-059B5219-EF04-410D-BE3A-BD671631BA50Q33636255-D3C6FE44-57C3-4452-B549-21B73D1C384EQ33933900-BA05CD66-373B-40CA-95D8-25BFEC3D28E3Q34496769-226A66CB-4175-4A35-8EC1-E8719FA131B4Q35552267-5A6C1B34-32FF-40E7-B693-85CDF9408C43Q35842827-4A20481D-B145-4D8B-BAD9-EFB93D0DEFA6Q36042707-36F4DB76-AFD6-44E2-859C-9AC881A54C62Q36150037-D674D8C7-8747-4256-9C1D-E1AB0166469AQ36474797-BD667F60-8A73-4172-A287-4E8AA1AC8F1BQ36643376-8C3B4569-99CA-4619-98F0-18CCC7F196A5Q36868348-ACE5E24C-B14F-4536-AC38-196677A0274DQ36929955-58BDEA9E-CE0B-46B4-ACB7-83DB010894BFQ36939082-B2B8850A-ACB2-44D6-A853-19EE8FC78870Q37184539-A49CBC94-D9EF-49BA-833C-39A4C408E087Q37931976-9504C31B-BCEC-40BC-843F-91D129E3458BQ38124916-3B9F0336-4A6A-4579-AF9E-9FDC92042642Q38303833-2A6E0732-4B70-4BC8-AD09-FC8AF6AF54A1Q39024971-E3BF81FC-A3EB-4D80-96CD-3EE2406E467EQ39502485-FD375F6D-8589-49AE-AED7-C9A9F7F39B24Q43165524-D02BC922-37D9-446D-8FB3-6C1E5151A000Q43888498-852191C4-BBEE-4821-B71B-52A0E61171F4Q45199029-C30E68F9-8C95-4D6C-B16C-C46708C8D338Q47157430-CA50EDA0-A21E-41B3-8133-3648571F4BFAQ49751447-BEA4CA4A-FAD0-41BF-9EF1-014AA22D7814Q51767184-A326E5D9-7785-4828-A51C-A960D94F96BBQ52346831-15DD8208-6F99-4451-AC4B-419BF837F9BFQ58801346-4765725D-0EDC-4A6B-9199-57CDEA595B85
P2860
The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The molecular characteristics ...... y human ovary cDNA microarray.
@ast
The molecular characteristics ...... y human ovary cDNA microarray.
@en
type
label
The molecular characteristics ...... y human ovary cDNA microarray.
@ast
The molecular characteristics ...... y human ovary cDNA microarray.
@en
prefLabel
The molecular characteristics ...... y human ovary cDNA microarray.
@ast
The molecular characteristics ...... y human ovary cDNA microarray.
@en
P2093
P356
P1476
The molecular characteristics ...... y human ovary cDNA microarray.
@en
P2093
Fei-Yang Diao
Jiahao Sha
Jianmin Li
Jiayin Liu
Lirong Wang
Yadong Zhou
Zhiyang Xu
P356
10.1677/JME.0.0330059
P577
2004-08-01T00:00:00Z